Literature DB >> 21329725

Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.

Massimiliano Fabbiani, Laura Bracciale, Maria Doino, Alessandro D'Avino, Angela Marzocchetti, Pierluigi Navarra, Roberto Cauda, Andrea De Luca, Simona Di Giambenedetto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329725     DOI: 10.1016/j.jinf.2011.02.004

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

1.  Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.

Authors:  Mattia C F Prosperi; Massimiliano Fabbiani; Iuri Fanti; Mauro Zaccarelli; Manuela Colafigli; Annalisa Mondi; Alessandro D'Avino; Alberto Borghetti; Roberto Cauda; Simona Di Giambenedetto
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

2.  Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis.

Authors:  C I Marinescu; M Leyes; M A Ribas; M Peñaranda; J Murillas; A A Campins; L Martin-Pena; B Barcelo; C Barceló-Campomar; F Grases; G Frontera; Melchor Riera Jaume
Journal:  AIDS Res Treat       Date:  2015-05-07

Review 3.  HIV medication-based urolithiasis.

Authors:  Hassane Izzedine; François Xavier Lescure; Fabrice Bonnet
Journal:  Clin Kidney J       Date:  2014-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.